{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/itch-widespread/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"d34f3906-2823-5407-8f4d-32157480544d","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 4f493ba9-c78a-4d94-973b-2d9ed55cbb27 --><h2>Changes</h2><!-- end field 4f493ba9-c78a-4d94-973b-2d9ed55cbb27 -->","summary":null,"htmlStringContent":"<!-- begin item 109ab6c3-96a4-49b0-8f02-30859670be46 --><!-- begin field 36c92856-928b-48e6-9123-f61cad5c23d5 --><p><strong>December 2016</strong> &mdash; minor update. The adverse effects of hyroxyzine have been updated in line with the manufacturer&#39;s Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/itch-widespread/references/\">ABPI, 2016</a>].</p><p><strong>October to November 2015 </strong>&mdash; reviewed.&nbsp;A literature search was conducted in September 2015 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic.&nbsp;The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations.&nbsp;</p><!-- end field 36c92856-928b-48e6-9123-f61cad5c23d5 --><!-- end item 109ab6c3-96a4-49b0-8f02-30859670be46 -->","topic":{"id":"98db983b-94d0-57fc-8f85-3c35dffdbc84","topicId":"3ff60e1b-3717-41cc-be12-1871b4284ba6","topicName":"Itch - widespread","slug":"itch-widespread","lastRevised":"Last revised in December 2016","chapters":[{"id":"c31a1ea7-3548-5767-9a55-10f56f4ea14a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"316853c8-d1ca-5613-8c4d-c33ea7c0fd8b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"64abf965-05aa-566d-999c-e216708a87b3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d34f3906-2823-5407-8f4d-32157480544d","slug":"changes","fullItemName":"Changes"},{"id":"8981751b-abe1-515d-b935-74b8a9b645f8","slug":"update","fullItemName":"Update"}]},{"id":"e1e55a0f-0001-592a-92fd-aacfa519336f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f8e85ce4-cb59-5950-9bb6-f4cc07f650a5","slug":"goals","fullItemName":"Goals"},{"id":"49927afa-5b0d-5fc5-9977-b9fbb4cb4db9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0cdcfdc7-2628-54da-8125-7d0470463e91","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9249d5b2-8df4-5432-adc8-2c07129d2033","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"60200ae0-6fe3-5aac-ba12-bfadcd7364eb","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f57416b9-dc21-5b4f-b045-1a09f5148e92","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b96f535e-5376-53fa-b81c-21c88d0b344f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5e603eed-2553-5ec5-8250-3b6ff59aa984","slug":"definition","fullItemName":"Definition"},{"id":"5d85e75d-599f-583b-843d-861aeef9a901","slug":"causes","fullItemName":"Causes"},{"id":"ac8f2843-31dd-59dc-a6ea-cb91a03a2ff5","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0a022a03-81bf-5f1b-a367-0ecb842aa8b3","slug":"complications","fullItemName":"Complications"}]},{"id":"5520e3e5-dfa1-5437-aeef-2256ca61fbb4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1cf86197-a1ad-58fc-b46d-d2814ed58a17","slug":"history-examination","fullItemName":"History and examination"},{"id":"3b7bfad0-4337-523a-99e2-a2d249319c14","slug":"investigations","fullItemName":"Investigations"}]},{"id":"5da46787-c48f-5e2c-85d7-6a9a17e04771","fullItemName":"Management","slug":"management","subChapters":[{"id":"136349ec-02aa-57d6-97eb-349a8b186b91","slug":"management-of-widespread-itch","fullItemName":"Scenario: Management of widespread itch"}]},{"id":"a5778d5a-8940-58a1-82e1-4801b7a7ea9f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"df24164a-a18e-5781-af2c-9d5424983d04","slug":"chlorphenamine","fullItemName":"Chlorphenamine"},{"id":"d3b77011-f1f7-5074-ac46-2c0f5e15406a","slug":"hydroxyzine","fullItemName":"Hydroxyzine"}]},{"id":"3bc21e68-6ddb-5e67-9f24-6b13787b7d3c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"2ebcf77c-c92c-5ef1-9321-590d2e905484","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bff96b70-ee2f-5eed-a1ab-c601465837a3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"76e9e0da-5a28-5e8f-a6a8-e08786d8da0e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"838c111d-a9e4-5085-b44a-6f220b2e7f9a","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8df3d2d7-e38f-5310-8b24-a8509771d9cd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"74b7f8a8-8f89-5100-ad47-3f6c473ccaf7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f3e3af3a-d360-5e56-8053-6ff53dac1096","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"64abf965-05aa-566d-999c-e216708a87b3","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"3314ad63-16b3-503f-bfd9-869d8d326017","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 4d4a1c9e-afc9-4e2c-95cf-0c975b054554 --><h3>Previous changes</h3><!-- end field 4d4a1c9e-afc9-4e2c-95cf-0c975b054554 -->","summary":null,"htmlStringContent":"<!-- begin item baf57e50-e9c7-4e8c-959c-db1b2989a995 --><!-- begin field 45c3582c-2eb6-450a-82a2-0fabdd452a74 --><p><strong>October 2009 to February 2010 </strong>&mdash; this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field 45c3582c-2eb6-450a-82a2-0fabdd452a74 --><!-- end item baf57e50-e9c7-4e8c-959c-db1b2989a995 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}